The following stories appear in full on Today's Vidyya Medical News Service Web site.
24 March 24 2001, will mark the 19th annual World TB Day, which recognizes the collaborative efforts of all countries involved in eliminating tuberculosis (TB). TB is the second leading cause of death among infectious diseases worldwide. An estimated 2 billion persons---one third of the world's population---are infected with the bacteria that cause TB, and approximately 2 million persons die each year from TB.
For more information: Tomorrow Is World TB Day -- 24 March 2001
During the 1990s, the number of tuberculosis (TB) cases increased dramatically in the Russian Federation, and the rise paralleled concomitant increases in TB-associated mortality. In November 1998, the World Health Organization (WHO), the U.S. Agency for International Development, and CDC, in collaboration with the Central Tuberculosis Research Institute of the Russian Academy of Medical Sciences and the Russian Ministry of Health, identified three regions as demonstration sites for implementing a WHO control strategy program of directly observed treatment short-course (DOTS). The program was designed to provide comprehensive TB care to both civilian and prison populations within each region (oblast), and periodic cohort analyses of treatment outcomes were recommended to evaluate its progress. This report summarizes evaluations of treatment outcomes for patients enrolled during the first 6 months of the project.
For more information: Evaluation Of A Directly Observed Therapy Short-Course Strategy For Treating Tuberculosis -- Orel Oblast, Russian Federation, 1999--2000
Do estrogens, wood dust, a common solvent called trichloroethylene, the flavoring methyleugenol and the antibiotic chloramphenicol cause human cancer under some circumstances? The National Toxicology Program, headquartered at the National Institute of Environmental Health Sciences, is seeking final public comments and data on these and several other substances and exposures before recommending whether to list them as human carcinogens in the federal government's tenth and newest Report on Carcinogens.
For more information: US Federal Government Makes Final Call for Data, Public Comment Before Writing New Report On Cancer-Causing Substances
The Food and Drug Administration today approved a wristwatch-like device that provides adult diabetics with more information for managing their disease. It is intended for use along with, not as a replacement for, finger-prick blood tests to monitor glucose. The GlucoWatch Biographer, made by Cygnus Inc., of Redwood City, Calif., extracts fluid through the skin by sending out tiny electric currents. Glucose levels are measured using this fluid every 20 minutes for 12 hours-even during sleep.
For more information: FDA Approves New Glucose Test For Adult Diabetics
Hoffmann-La Roche Inc. announced today that it has submitted a supplemental application to the U.S. Food and Drug Administration (FDA) for a new indication for its prescription weight loss medication Xenical® (orlistat) to improve glycemic control when used as an adjunct to other antidiabetic treatments in overweight or obese patients with type 2 diabetes.
For more information: New Indication For Xenical® Sought By Roche Pharmaceuticals
Today's Vidyya articles are:
As always, we hope you enjoy the issue.